Loading company…
Ruichu Medicine develops drugs for neurodegenerative, fibrotic, and inflammatory diseases.
Founded in 2021 and based in Nanjing, China, Ruichu Medicine develops therapeutic drugs for degenerative diseases, including neurodegenerative, fibrotic, and inflammatory conditions. Its founding team has more than 10 years of ageing research experience. In May 2024, the company raised over CNY 100 million in pre-Series A funding led by Lapam Capital to advance its projects toward clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in